Bioten바이오텐
289170 · KONEX · ₩289170 · 바이오텐
- Market cap
- ₩9.7B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- ROE
- —
- Net margin
- —
Financial statements not available yet. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−43.5% from the high
₩2,000Today: ₩2,700 – ₩2,700₩4,775
Returns
- 1W−9.7%
- 1M0.0%
- 3M+2.1%
- 6M−17.2%
- YTD−24.2%
- 1Y−30.4%
- Volume today
- 10
- 0.3× the 20-day average
- Traded today
- ₩27,000
- Listed shares
- 3,576,689
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 32 of 100 (50 is a normal day for this stock).
- MomentumFlat0.4% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Bioten stock overview
Bioten (바이오텐, KRX: 289170) is listed on KONEX, in the Food & Beverage sector. , Ltd. Its shares closed at ₩2,700 on Oct 29, 2026, down 2.88% on the day, giving it a market value of ₩9.7B.
Key facts
- Market cap
- ₩9.7B
- Sector
- Food & Beverage
- Latest price change
- −2.88%
- As of
- Oct 29, 2026
- Main business
- , Ltd.
Quick answers about Bioten
- What does Bioten do?
- , Ltd. is a Korean company that develops composite materials made from natural ingredients, using techniques that improve bioavailability and functionality, including its curcuminoid complexes TSP and TGP. It sells 15 health functional food products and 26 feed supplement products, and it is expanding overseas, with exports beginning in China and trademark registration and approval procedures underway in the United States, Indonesia, and Vietnam.
- What is the market cap of Bioten?
- The market capitalisation of Bioten was ₩9.7B at the close on Oct 29, 2026.
- Who are the largest shareholders of Bioten?
- According to the latest official filings, the largest reported holders are Kim Young-cheol (25.95%, as of Nov 6, 2025); Fine Value Asset Management (15.27%, as of Nov 19, 2024).
- When is the next earnings report from Bioten?
- Korean companies rarely announce results dates in advance. Based on when Bioten filed the same report in past years, its next annual results is expected between Mar 18, 2027 and Mar 23, 2027.
Company profile
Bio10 Co., Ltd. is a Korean company that develops composite materials made from natural ingredients, using techniques that improve bioavailability and functionality, including its curcuminoid complexes TSP and TGP. It sells 15 health functional food products and 26 feed supplement products, and it is expanding overseas, with exports beginning in China and trademark registration and approval procedures underway in the United States, Indonesia, and Vietnam.
Written by AI from the company's latest annual report.
- Korean name
- 바이오텐
- Sector
- Food & Beverage
- Themes
- —
- CEO
- 김영철, 이우송(각자대표)
- Founded
- Oct 2010
- Listed
- Oct 2023
- Listed shares
- 3,576,689
- Fiscal year ends
- Month 12
- Website
- www.bioten.co.kr
Similar companies
- Samyang Foods003230 · ₩8.6T₩1,142,000−4.19%
- Orion271560 · ₩4.5T₩112,900+1.26%
- CJ Cheiljedang097950 · ₩2.6T₩171,300+0.88%
- Nongshim004370 · ₩2.4T₩388,000−0.39%
- Otoki007310 · ₩1.3T₩314,500+2.11%
- Hite Jinro000080 · ₩1.1T₩15,600+0.97%
- Lotte Wellfood280360 · ₩1.1T₩117,600+0.68%
- Lotte Chilsung Beverage005300 · ₩899B₩96,900+1.04%
Recent filings
See all- Change of CEOJul 21, 2026
- Investor relations (IR) eventJun 30, 2026
- Annual general meeting resultsMar 31, 2026
- Audit report submittedMar 23, 2026
- Annual report (Dec 2025)Mar 23, 2026
Titles in Korean until English translations are added.
Also known as: Bioten / 바이오텐 / 289170 / KRX:289170
Source: KRX statistical information